Selected research
Industry Growth & Trends
Global Live Cell Imaging Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Live Cell Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Live Cell Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Live Cell Imaging Software market include Andor Technology, Fluxion Biosciences, Olympus LS, PerkinElmer, Sartorius, Molecular Devices, Phase Holographic Imaging PHI, Agilent and BioTek, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Live Cell Imaging Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Live Cell Imaging Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Live Cell Imaging Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Live Cell Imaging Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Live Cell Imaging Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Live Cell Imaging Software Market by Company
Andor Technology
Fluxion Biosciences
Olympus LS
PerkinElmer
Sartorius
Molecular Devices
Phase Holographic Imaging PHI
Agilent
BioTek
Nanlive
CytoSMART
AutoLCI
MilliporeSigma
Live Cell Imaging Software Segment by Type
Cloud-based
On Premises
Live Cell Imaging Software Segment by Application
Laboratory
Hospital
Others
Live Cell Imaging Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Live Cell Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Imaging Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Live Cell Imaging Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On Premises
Applications
- Laboratory
- Hospital
- Others
Companies covered
- Andor Technology
- Fluxion Biosciences
- Olympus LS
- PerkinElmer
- Sartorius
- Molecular Devices
- Phase Holographic Imaging PHI
- Agilent
- BioTek
- Nanlive
- CytoSMART
- AutoLCI
- MilliporeSigma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Live Cell Imaging Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Live Cell Imaging Software Market Size by Region (2021-2032)
- 1.4.1 Global Live Cell Imaging Software Market Size by Region (2021-2026)
- 1.4.2 Global Live Cell Imaging Software Market Size by Region (2027-2032)
- 1.5 Key Regions Live Cell Imaging Software Market Size (2021-2032)
- 1.5.1 North America Live Cell Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Live Cell Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Live Cell Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Live Cell Imaging Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Live Cell Imaging Software Market Size Growth Rate (2021-2032)
2 Live Cell Imaging Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud-based
- 2.1.2 On Premises
- 2.2 Global Live Cell Imaging Software Market Size by Type
- 2.2.1 Global Live Cell Imaging Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Live Cell Imaging Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Live Cell Imaging Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Live Cell Imaging Software Market Size by Regions
- 2.3.1 North America Live Cell Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Live Cell Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Live Cell Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Live Cell Imaging Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Live Cell Imaging Software Market Size Breakdown by Type (2021-2026)
3 Live Cell Imaging Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Laboratory
- 3.1.2 Hospital
- 3.1.3 Others
- 3.2 Global Live Cell Imaging Software Market Size by Application
- 3.2.1 Global Live Cell Imaging Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Live Cell Imaging Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Live Cell Imaging Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Live Cell Imaging Software Market Size by Regions
- 3.3.1 North America Live Cell Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Live Cell Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Live Cell Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Live Cell Imaging Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Live Cell Imaging Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Live Cell Imaging Software Industry Trends
- 4.2 Live Cell Imaging Software Industry Drivers
- 4.3 Live Cell Imaging Software Industry Opportunities and Challenges
- 4.4 Live Cell Imaging Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Live Cell Imaging Software Revenue (2021-2026)
- 5.2 Global Live Cell Imaging Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Live Cell Imaging Software Key Company Headquarters & Area Served
- 5.4 Global Live Cell Imaging Software Company, Product Type & Application
- 5.5 Global Live Cell Imaging Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Live Cell Imaging Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Live Cell Imaging Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Live Cell Imaging Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Andor Technology
- 6.1.1 Andor Technology Company Information
- 6.1.2 Andor Technology Business Overview
- 6.1.3 Andor Technology Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Andor Technology Live Cell Imaging Software Product Portfolio
- 6.1.5 Andor Technology Recent Developments
- 6.2 Fluxion Biosciences
- 6.2.1 Fluxion Biosciences Company Information
- 6.2.2 Fluxion Biosciences Business Overview
- 6.2.3 Fluxion Biosciences Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Fluxion Biosciences Live Cell Imaging Software Product Portfolio
- 6.2.5 Fluxion Biosciences Recent Developments
- 6.3 Olympus LS
- 6.3.1 Olympus LS Company Information
- 6.3.2 Olympus LS Business Overview
- 6.3.3 Olympus LS Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Olympus LS Live Cell Imaging Software Product Portfolio
- 6.3.5 Olympus LS Recent Developments
- 6.4 PerkinElmer
- 6.4.1 PerkinElmer Company Information
- 6.4.2 PerkinElmer Business Overview
- 6.4.3 PerkinElmer Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 PerkinElmer Live Cell Imaging Software Product Portfolio
- 6.4.5 PerkinElmer Recent Developments
- 6.5 Sartorius
- 6.5.1 Sartorius Company Information
- 6.5.2 Sartorius Business Overview
- 6.5.3 Sartorius Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sartorius Live Cell Imaging Software Product Portfolio
- 6.5.5 Sartorius Recent Developments
- 6.6 Molecular Devices
- 6.6.1 Molecular Devices Company Information
- 6.6.2 Molecular Devices Business Overview
- 6.6.3 Molecular Devices Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Molecular Devices Live Cell Imaging Software Product Portfolio
- 6.6.5 Molecular Devices Recent Developments
- 6.7 Phase Holographic Imaging PHI
- 6.7.1 Phase Holographic Imaging PHI Company Information
- 6.7.2 Phase Holographic Imaging PHI Business Overview
- 6.7.3 Phase Holographic Imaging PHI Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Phase Holographic Imaging PHI Live Cell Imaging Software Product Portfolio
- 6.7.5 Phase Holographic Imaging PHI Recent Developments
- 6.8 Agilent
- 6.8.1 Agilent Company Information
- 6.8.2 Agilent Business Overview
- 6.8.3 Agilent Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Agilent Live Cell Imaging Software Product Portfolio
- 6.8.5 Agilent Recent Developments
- 6.9 BioTek
- 6.9.1 BioTek Company Information
- 6.9.2 BioTek Business Overview
- 6.9.3 BioTek Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BioTek Live Cell Imaging Software Product Portfolio
- 6.9.5 BioTek Recent Developments
- 6.10 Nanlive
- 6.10.1 Nanlive Company Information
- 6.10.2 Nanlive Business Overview
- 6.10.3 Nanlive Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Nanlive Live Cell Imaging Software Product Portfolio
- 6.10.5 Nanlive Recent Developments
- 6.11 CytoSMART
- 6.11.1 CytoSMART Company Information
- 6.11.2 CytoSMART Business Overview
- 6.11.3 CytoSMART Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 CytoSMART Live Cell Imaging Software Product Portfolio
- 6.11.5 CytoSMART Recent Developments
- 6.12 AutoLCI
- 6.12.1 AutoLCI Company Information
- 6.12.2 AutoLCI Business Overview
- 6.12.3 AutoLCI Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 AutoLCI Live Cell Imaging Software Product Portfolio
- 6.12.5 AutoLCI Recent Developments
- 6.13 MilliporeSigma
- 6.13.1 MilliporeSigma Company Information
- 6.13.2 MilliporeSigma Business Overview
- 6.13.3 MilliporeSigma Live Cell Imaging Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 MilliporeSigma Live Cell Imaging Software Product Portfolio
- 6.13.5 MilliporeSigma Recent Developments
7 North America
- 7.1 North America Live Cell Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Live Cell Imaging Software Market Size by Country (2021-2026)
- 7.3 North America Live Cell Imaging Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Live Cell Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Live Cell Imaging Software Market Size by Country (2021-2026)
- 8.3 Europe Live Cell Imaging Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Live Cell Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Live Cell Imaging Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Live Cell Imaging Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Live Cell Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Live Cell Imaging Software Market Size by Country (2021-2026)
- 10.3 South America Live Cell Imaging Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Live Cell Imaging Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Live Cell Imaging Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Live Cell Imaging Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst